Zurzuvae - Can men take this for MDD?

Zurzuvae (zuranolone) is used to treat postpartum depression (PPD), it is a rapid-acting, once-daily capsule taken for 14 days. Zurzuvae works quickly to improve depression symptoms compared to current treatment options, which may take weeks or months to work. Zurzuvae is the first oral medication FDA-approved to treat postpartum depression.

Zurzuvae is the brand name for zuranolone, and during development, it was called SAGE-217 and BIIB125.

Postpartum depression is a major depressive episode that can occur after childbirth but can also start during the later stages of pregnancy. PPD is a serious condition in which women may feel intense anxiety, sadness, shame, guilt, problems sleeping, stress, panic attacks, and suicidal thoughts or attempts. This can make it difficult for mothers to care for and bond with their babies and may delay the child's physical and emotional development.

Source: https://www.drugs.com/zurzuvae.html

Medications for Major Depressive Disorder

Source: https://www.drugs.com/condition/major-depressive-disorder.html